The deal is expected to close in the third quarter, subject to approval from the TSX Venture Exchange.
Under the plan announced from London and Vancouver, the U.K.-based company will invest 75 million pounds in a debenture that's convertible into Auxly equity at 81 cents per share. The conversion price is 11 per cent above Auxly's closing share price at the TSX Venture Exchange on Wednesday.In addition to the funds and technology licences, Auxly will get access to Imperial's Nerudia innovation business and become Imperial's exclusive global partner for future cannabis products.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: